[HTML][HTML] SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

S Jangra, C Ye, R Rathnasinghe, D Stadlbauer… - The Lancet …, 2021 - thelancet.com
It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein …

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

S Jangra, C Ye, R Rathnasinghe, D Stadlbauer… - The Lancet …, 2021 - ncbi.nlm.nih.gov
It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein …

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

S Jangra, C Ye, R Rathnasinghe, D Stadlbauer… - 2021 - agris.fao.org
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation Food and Agriculture
Organization of the United Nations Discover About FAO News Multimedia Main topics Statistics …

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.

S Jangra, C Ye, R Rathnasinghe, D Stadlbauer… - The Lancet …, 2021 - europepmc.org
It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein …

[引用][C] SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

S Jangra, C Ye, R Rathnasinghe, D Stadlbauer… - The Lancet …, 2021 - cir.nii.ac.jp
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

S Jangra, C Ye, R Rathnasinghe… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation SARS-CoV-2 spike E484K
mutation reduces antibody neutralisation Lancet Microbe. 2021 Jul;2(7):e283-e284. doi …

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.

S Jangra, C Ye, R Rathnasinghe, D Stadlbauer… - The Lancet …, 2021 - europepmc.org
It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein …